Repligen Co. (NASDAQ:RGEN) Receives Consensus ... - MarketBeat

3 days ago · Shares of Repligen Co. (NASDAQ:RGEN - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the thirteen research firms that are …

$197.75
OFF

Brokerages Set Repligen Co. (NASDAQ:RGEN) PT At $197.75

2 weeks from now

Jun 1, 2024 · Shares of Repligen Co. (NASDAQ:RGEN - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the nine ratings firms that are currently …

marketbeat.com

$185.20
OFF

Repligen Co. (NASDAQ:RGEN) Receives $185.20 Consensus Price …

2 weeks from now

Dec 21, 2024 · Repligen Co. (NASDAQ:RGEN – Get Free Report) has earned a consensus rating of “Moderate Buy” from the thirteen ratings firms that are covering the company, Marketbeat …

americanbankingnews.com

$185.20
OFF

Analysts Set Repligen Co. (NASDAQ:RGEN) Price Target At $185.20

2 weeks from now

6 hours ago · Shares of Repligen Co. (NASDAQ:RGEN – Get Free Report) have earned an average recommendation of “Moderate Buy” from the thirteen research firms that are presently …

etfdailynews.com

$0.43
OFF

Repligen (RGEN) Earnings Date And Reports 2025 - MarketBeat

2 weeks from now

1 day ago · In the previous quarter, Repligen (NASDAQ:RGEN) reported $0.43 earnings per share (EPS) to beat the analysts' consensus estimate of $0.34 by $0.09. Learn more on …

marketbeat.com

$158.14
OFF

Repligen Co. (NASDAQ:RGEN) Given Consensus ... - ETF Daily News

2 weeks from now

Dec 18, 2024 · Shares of RGEN opened at $158.14 on Wednesday. The company has a market cap of $8.86 billion, a PE ratio of -427.41, a price-to-earnings-growth ratio of 4.64 and a beta …

etfdailynews.com

2%
OFF

Repligen Co. (NASDAQ:RGEN) Shares Bought By GAMMA …

2 weeks from now

4 days ago · GAMMA Investing LLC boosted its stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 15.2% in the fourth quarter, according to its most recent 13F filing with the …

etfdailynews.com

6%
OFF

Repligen Corp. (RGEN) News, Articles, Events & Latest Updates

2 weeks from now

Repligen reports Q2 sales of $154.1 million, closely matching the consensus estimate. Adjusted gross margin fell to 49.6% from 50.2%, with an EPS of $0.33. ... Repligen Co. …

stocktwits.com

FAQs about Repligen Co. (NASDAQ:RGEN) Receives Consensus ... - MarketBeat Coupon?

Should you buy Repligen co (RGEN) stock?

Shares of Repligen Co. (NASDAQ:RGEN – Get Free Report) have earned an average recommendation of “Moderate Buy” from the thirteen research firms that are presently covering the stock, Marketbeat Ratings reports. Five analysts have rated the stock with a hold rating and eight have given a buy rating to the company. ...

Is Repligen a good stock to buy?

Wolfe Research assumed coverage on shares of Repligen in a report on Thursday, November 14th. They set a “peer perform” rating for the company. Finally, Canaccord Genuity Group assumed coverage on Repligen in a research note on Tuesday, December 17th. They issued a “hold” rating and a $165.00 price target on the stock. ...

What is the average 12 month price target for Repligen?

The average 12 month price target among analysts that have issued ratings on the stock in the last year is $185.20. A number of equities analysts have issued reports on the company. StockNews.com upgraded Repligen from a “sell” rating to a “hold” rating in a report on Friday, January 3rd. ...

How much will Repligen (Repligen) earn per share?

On average, sell-side analysts expect that Repligen will post 1.54 earnings per share for the current year. (Get Free Report Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. ...

Who owns Repligen (RGEN)?

Finally, nVerses Capital LLC bought a new stake in shares of Repligen in the third quarter worth approximately $45,000. 97.64% of the stock is currently owned by hedge funds and other institutional investors. Shares of NASDAQ RGEN opened at $156.55 on Friday. Repligen has a 1 year low of $113.50 and a 1 year high of $211.13. ...

How do I receive news & ratings for Repligen?

Receive News & Ratings for Repligen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Repligen and related companies with MarketBeat.com's FREE daily email newsletter. ...